Atlas Trials

Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer

Clinical trial NCT02195973 · COMPLETED

Trial details

NCT number
NCT02195973
Sponsor
University of Alabama at Birmingham
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Ovarian Cancer
Start date
2014-09-01
Primary completion
2016-12-10
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.